Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | BMC Molecular and Cell Biology

Fig. 2

From: Fyn kinase regulates dopaminergic neuronal apoptosis in animal and cell models of high glucose (HG) treatment

Fig. 2

HG treatment induces apoptotic death and activates Fyn and mTOR/S6K in differentiated SH-SY5Y cells. (A) Cleaved caspase 3caspase 3 levels in the HG (75 mM, 6 days) group were higher than those in the control group. The grouping of blots cropped from different parts of the same gel is shown. (B) Cell viability was significantly lower in the HG group than in the control group (n = 5). (C) Annexin V-FITC-positive cells were significantly increased in response to HG treatment compared to controls (n = 3). (D) p-Y416 was obviously higher in the HG group than in the control group (n = 5). The blots of β-actin and Fyn were cropped from different parts of the same gel, and p-Y416 was cropped from different gels. (E) mRNA levels of Fyn were not changed by HG treatment (n = 3) (F) p-mTOR and p-S6K in HG group were significantly higher, but total mTOR and S6K were comparable (n = 5). β-actin and S6K were cropped from different parts of the same gel, and the p-S6K, mTOR and p-mTOR were cropped from different gels

Back to article page

BMC Molecular and Cell Biology

ISSN: 2661-8850

Contact us